相关实验视频

Updated: Jun 6, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

使用UMD-DMD数据库对杜申肌肉发育不良症的外显子跳转适用性的最新分析

Jamie Leckie¹, Abdullah Zia¹, Toshifumi Yokota^1,2

¹Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.

|November 27, 2024

概括

反感性寡核酸 (ASO) 异子跳转疗法对杜申肌肉发育不良 (DMD) 具有前景. 这项研究分析了理论策略,揭示了超越目前FDA批准的治疗方法治疗更广泛的DMD患者群体的潜力.

科学领域:

遗传学和分子生物学
神经肌肉疾病神经肌肉疾病
药物开发药物开发

背景情况:

反感性寡核酸 (ASO) 介导的外因子跳转是杜申肌肉发育不良 (DMD) 的治疗策略,通过恢复基因读取框架.
目前FDA批准的ASO针对特定突变,限制DMD患者的一个子集的治疗可用性.
全面了解外体跳转的适用性对于开发具有更广泛患者覆盖范围的新疗法至关重要.

研究的目的:

分析各种对DMD突变的外型跳转策略的理论适用性.
为了确定潜在的外显子目标,可以使更多的DMD患者受益.
通过整合突变和表型数据,提供临床相关的视角.

主要方法:

评估了单个,双重和多个表因子跳过策略的理论适用性.
包括针对 3-9 和 45-55 元区的目标跳过元区的方法.
利用UMD-DMD数据库,结合表型数据进行全面分析.

主要成果:

单个和双个突变突变跳转策略在突变类型中显示出很高的适用性 (总体为90.3%).
埃克森51成为关键标,适用于所有DMD突变的10.6%.
多个表原体跳转 (表原体45-55和3-9) 对于大缺失 (70.6%) 和小病变 (19.2%) 具有显著的相关性.

结论:

目前FDA批准的ASO仅适用于分析的DMD病例的27%.
对于替代性跳过外星子策略来扩大治疗可访问性,存在很大的潜力.
这些更广泛的方法的临床转化对于改善DMD患者的治疗结果至关重要.

关键词:

贝克尔肌肉发育不良 (BMD)杜恩肌肉发育不良 (DMD)这是一种反感性寡核酸 (ASO).适用性适用性适用性消极蛋白质是一种消极蛋白质.跳过的前期跳过.

更多相关视频

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

相关概念视频

Exon Recombination

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...